Is ZEPP or MDXH more profitable?

Zepp Health has a net margin of -14.70% compared to MDxHealth's net margin of -29.90%. MDxHealth's return on equity of 0.00% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% MDxHealth -29.90% N/A -22.51%

Does the media refer more to ZEPP or MDXH?

In the previous week, Zepp Health had 1 more articles in the media than MDxHealth. MarketBeat recorded 4 mentions for Zepp Health and 3 mentions for MDxHealth. Zepp Health's average media sentiment score of 0.22 beat MDxHealth's score of 0.05 indicating that Zepp Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zepp Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MDxHealth 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, NYXH or MDXH?

MDxHealth has higher revenue and earnings than Nyxoah. MDxHealth is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nyxoah $11.33M 5.88 -$101.92M -$2.48 N/A MDxHealth $107.88M 0.22 -$33.52M -$0.65 N/A

Is NYXH or MDXH more profitable?

MDxHealth has a net margin of -29.90% compared to Nyxoah's net margin of -543.21%. MDxHealth's return on equity of 0.00% beat Nyxoah's return on equity. Company Net Margins Return on Equity Return on Assets Nyxoah -543.21% -163.73% -80.24% MDxHealth -29.90% N/A -22.51%

Does the media refer more to NYXH or MDXH?

In the previous week, Nyxoah and Nyxoah both had 3 articles in the media. MDxHealth's average media sentiment score of 0.05 beat Nyxoah's score of 0.00 indicating that MDxHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MDxHealth 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, LUNG or MDXH?

MDxHealth has higher revenue and earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pulmonx $90.50M 0.65 -$54M -$1.30 N/A MDxHealth $107.88M 0.22 -$33.52M -$0.65 N/A

Is LUNG or MDXH more profitable?

MDxHealth has a net margin of -29.90% compared to Pulmonx's net margin of -60.09%. MDxHealth's return on equity of 0.00% beat Pulmonx's return on equity. Company Net Margins Return on Equity Return on Assets Pulmonx -60.09% -92.94% -39.80% MDxHealth -29.90% N/A -22.51%

Is MDXH or EUDA more profitable?

EUDA Health has a net margin of 0.00% compared to MDxHealth's net margin of -29.90%. Company Net Margins Return on Equity Return on Assets MDxHealth -29.90% N/A -22.51% EUDA Health N/A N/A N/A

Do analysts recommend MDXH or PRPO?

MDxHealth presently has a consensus price target of $4.63, suggesting a potential upside of 870.62%. Given MDxHealth's stronger consensus rating and higher possible upside, equities research analysts clearly believe MDxHealth is more favorable than Precipio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MDxHealth 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Precipio 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is MDXH or PRPO more profitable?

Precipio has a net margin of -3.57% compared to MDxHealth's net margin of -29.90%. MDxHealth's return on equity of 0.00% beat Precipio's return on equity. Company Net Margins Return on Equity Return on Assets MDxHealth -29.90% N/A -22.51% Precipio -3.57% -6.73% -4.49%

MDxHealth (MDXH) Competitors

$0.48 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$0.45 -0.03 (-6.40%)

As of 07/2/2026 07:42 PM Eastern

Compare

MDXH vs. ZEPP, NYXH, LUNG, EUDA, and PRPO

Should you buy MDxHealth stock or one of its competitors? MarketBeat compares MDxHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MDxHealth include Zepp Health (ZEPP), Nyxoah (NYXH), Pulmonx (LUNG), EUDA Health (EUDA), and Precipio (PRPO). These companies are all part of the "medical info sys" industry.

How does MDxHealth compare to Zepp Health?

Zepp Health (NYSE:ZEPP) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

In the previous week, Zepp Health had 1 more articles in the media than MDxHealth. MarketBeat recorded 4 mentions for Zepp Health and 3 mentions for MDxHealth. Zepp Health's average media sentiment score of 0.22 beat MDxHealth's score of 0.05 indicating that Zepp Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zepp Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MDxHealth	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

MDxHealth has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90M	0.29	-$40.07M	-$2.52	N/A
MDxHealth	$107.88M	0.22	-$33.52M	-$0.65	N/A

Zepp Health has a beta of 1.83, meaning that its share price is 83% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market.

Zepp Health has a net margin of -14.70% compared to MDxHealth's net margin of -29.90%. MDxHealth's return on equity of 0.00% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
MDxHealth	-29.90%	N/A	-22.51%

Zepp Health currently has a consensus price target of $56.28, suggesting a potential upside of 1,013.35%. MDxHealth has a consensus price target of $4.63, suggesting a potential upside of 870.62%. Given Zepp Health's higher possible upside, equities research analysts clearly believe Zepp Health is more favorable than MDxHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

52.6% of Zepp Health shares are held by institutional investors. 36.0% of Zepp Health shares are held by company insiders. Comparatively, 1.7% of MDxHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Zepp Health beats MDxHealth on 10 of the 16 factors compared between the two stocks.

How does MDxHealth compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation.

MDxHealth has a net margin of -29.90% compared to Nyxoah's net margin of -543.21%. MDxHealth's return on equity of 0.00% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-543.21%	-163.73%	-80.24%
MDxHealth	-29.90%	N/A	-22.51%

Nyxoah has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market.

In the previous week, Nyxoah and Nyxoah both had 3 articles in the media. MDxHealth's average media sentiment score of 0.05 beat Nyxoah's score of 0.00 indicating that MDxHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nyxoah	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MDxHealth	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

MDxHealth has higher revenue and earnings than Nyxoah. MDxHealth is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	5.88	-$101.92M	-$2.48	N/A
MDxHealth	$107.88M	0.22	-$33.52M	-$0.65	N/A

Nyxoah presently has a consensus target price of $7.00, indicating a potential upside of 306.98%. MDxHealth has a consensus target price of $4.63, indicating a potential upside of 870.62%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts plainly believe MDxHealth is more favorable than Nyxoah.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

MDxHealth beats Nyxoah on 10 of the 13 factors compared between the two stocks.

How does MDxHealth compare to Pulmonx?

Pulmonx (NASDAQ:LUNG) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Pulmonx presently has a consensus price target of $5.58, indicating a potential upside of 301.68%. MDxHealth has a consensus price target of $4.63, indicating a potential upside of 870.62%. Given MDxHealth's stronger consensus rating and higher probable upside, analysts clearly believe MDxHealth is more favorable than Pulmonx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, MDxHealth had 3 more articles in the media than Pulmonx. MarketBeat recorded 3 mentions for MDxHealth and 0 mentions for Pulmonx. MDxHealth's average media sentiment score of 0.05 beat Pulmonx's score of 0.00 indicating that MDxHealth is being referred to more favorably in the news media.

Company	Overall Sentiment
Pulmonx	Neutral
MDxHealth	Neutral

91.0% of Pulmonx shares are owned by institutional investors. 6.8% of Pulmonx shares are owned by company insiders. Comparatively, 1.7% of MDxHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Pulmonx has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

MDxHealth has higher revenue and earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmonx	$90.50M	0.65	-$54M	-$1.30	N/A
MDxHealth	$107.88M	0.22	-$33.52M	-$0.65	N/A

MDxHealth has a net margin of -29.90% compared to Pulmonx's net margin of -60.09%. MDxHealth's return on equity of 0.00% beat Pulmonx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmonx	-60.09%	-92.94%	-39.80%
MDxHealth	-29.90%	N/A	-22.51%

Summary

MDxHealth beats Pulmonx on 12 of the 15 factors compared between the two stocks.

How does MDxHealth compare to EUDA Health?

MDxHealth (NASDAQ:MDXH) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

4.4% of EUDA Health shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

MDxHealth has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, EUDA Health has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

In the previous week, MDxHealth had 3 more articles in the media than EUDA Health. MarketBeat recorded 3 mentions for MDxHealth and 0 mentions for EUDA Health. MDxHealth's average media sentiment score of 0.05 beat EUDA Health's score of 0.00 indicating that MDxHealth is being referred to more favorably in the media.

Company	Overall Sentiment
MDxHealth	Neutral
EUDA Health	Neutral

EUDA Health has lower revenue, but higher earnings than MDxHealth. EUDA Health is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MDxHealth	$107.88M	0.22	-$33.52M	-$0.65	N/A
EUDA Health	$6.82M	6.09	-$2.77M	-$2.40	N/A

EUDA Health has a net margin of 0.00% compared to MDxHealth's net margin of -29.90%.

Company	Net Margins	Return on Equity	Return on Assets
MDxHealth	-29.90%	N/A	-22.51%
EUDA Health	N/A	N/A	N/A

MDxHealth currently has a consensus target price of $4.63, suggesting a potential upside of 870.62%. EUDA Health has a consensus target price of $55.00, suggesting a potential upside of 296.25%. Given MDxHealth's stronger consensus rating and higher probable upside, equities research analysts plainly believe MDxHealth is more favorable than EUDA Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
EUDA Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

MDxHealth beats EUDA Health on 10 of the 15 factors compared between the two stocks.

How does MDxHealth compare to Precipio?

MDxHealth (NASDAQ:MDXH) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

MDxHealth has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market. Comparatively, Precipio has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

In the previous week, MDxHealth had 3 more articles in the media than Precipio. MarketBeat recorded 3 mentions for MDxHealth and 0 mentions for Precipio. MDxHealth's average media sentiment score of 0.05 beat Precipio's score of 0.00 indicating that MDxHealth is being referred to more favorably in the media.

Company	Overall Sentiment
MDxHealth	Neutral
Precipio	Neutral

MDxHealth presently has a consensus price target of $4.63, suggesting a potential upside of 870.62%. Given MDxHealth's stronger consensus rating and higher possible upside, equities research analysts clearly believe MDxHealth is more favorable than Precipio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Precipio	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Precipio has lower revenue, but higher earnings than MDxHealth. Precipio is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MDxHealth	$107.88M	0.22	-$33.52M	-$0.65	N/A
Precipio	$24.05M	1.88	-$360K	-$0.47	N/A

10.5% of Precipio shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by company insiders. Comparatively, 16.6% of Precipio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Precipio has a net margin of -3.57% compared to MDxHealth's net margin of -29.90%. MDxHealth's return on equity of 0.00% beat Precipio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MDxHealth	-29.90%	N/A	-22.51%
Precipio	-3.57%	-6.73%	-4.49%

Summary

MDxHealth beats Precipio on 9 of the 16 factors compared between the two stocks.

Get MDxHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDXH vs. The Competition

Export

Metric	MDxHealth	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$23.59M	$1.83B	$7.17B	$12.48B
Dividend Yield	N/A	N/A	2.66%	6.52%
P/E Ratio	-0.73	81.75	28.02	24.70
Price / Sales	0.22	7.15	540.72	98.05
Price / Cash	N/A	26.08	49.26	57.09
Price / Book	-1.99	5.75	10.96	6.46
Net Income	-$33.52M	-$54.76M	$3.57B	$337.01M
7 Day Performance	11.64%	2.95%	2.12%	1.69%
1 Month Performance	-15.80%	2.81%	5.25%	3.81%
1 Year Performance	-78.24%	-0.07%	33.29%	23.90%

MDxHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDXH MDxHealth	3.7267 of 5 stars	$0.48 flat	$4.63 +870.6%	-78.2%	$23.59M	$107.88M	N/A	300	News Coverage Gap Up
ZEPP Zepp Health	2.4301 of 5 stars	$5.17 +9.3%	$56.28 +988.6%	+69.6%	$69.44M	$258.90M	N/A	1,230
NYXH Nyxoah	2.3641 of 5 stars	$1.69 +2.4%	$7.00 +314.2%	-77.9%	$63.96M	$11.33M	N/A	110
LUNG Pulmonx	2.0003 of 5 stars	$1.30 -2.3%	$5.58 +329.5%	-49.9%	$56.17M	$90.50M	N/A	250	Gap Down
EUDA EUDA Health	2.4588 of 5 stars	$14.00 -5.4%	$55.00 +292.9%	-79.5%	$44.32M	$6.82M	N/A	2	Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDXH) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MDxHealth (MDXH) Competitors

MDXH vs. ZEPP, NYXH, LUNG, EUDA, and PRPO

How does MDxHealth compare to Zepp Health?

Summary

How does MDxHealth compare to Nyxoah?

Summary

How does MDxHealth compare to Pulmonx?

Summary

How does MDxHealth compare to EUDA Health?

Summary

How does MDxHealth compare to Precipio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MDxHealth (MDXH) Competitors

MDXH vs. ZEPP, NYXH, LUNG, EUDA, and PRPO

How does MDxHealth compare to Zepp Health?

Does the media refer more to ZEPP or MDXH?

Which has preferable earnings & valuation, ZEPP or MDXH?

Which has more volatility and risk, ZEPP or MDXH?

Is ZEPP or MDXH more profitable?

Do analysts prefer ZEPP or MDXH?

Do institutionals & insiders believe in ZEPP or MDXH?

Summary

How does MDxHealth compare to Nyxoah?

Is NYXH or MDXH more profitable?

Which has more risk & volatility, NYXH or MDXH?

Does the media refer more to NYXH or MDXH?

Which has stronger valuation & earnings, NYXH or MDXH?

Do analysts prefer NYXH or MDXH?

Summary

How does MDxHealth compare to Pulmonx?

Do analysts prefer LUNG or MDXH?

Does the media refer more to LUNG or MDXH?

Do insiders and institutionals believe in LUNG or MDXH?

Which has more volatility & risk, LUNG or MDXH?

Which has better earnings and valuation, LUNG or MDXH?

Is LUNG or MDXH more profitable?

Summary

How does MDxHealth compare to EUDA Health?

Do insiders & institutionals hold more shares of MDXH or EUDA?

Which has more volatility & risk, MDXH or EUDA?

Does the media prefer MDXH or EUDA?

Which has stronger earnings & valuation, MDXH or EUDA?

Is MDXH or EUDA more profitable?

Do analysts recommend MDXH or EUDA?

Summary

How does MDxHealth compare to Precipio?

Which has more volatility and risk, MDXH or PRPO?

Does the media favor MDXH or PRPO?

Do analysts recommend MDXH or PRPO?

Which has better valuation & earnings, MDXH or PRPO?

Do insiders and institutionals hold more shares of MDXH or PRPO?

Is MDXH or PRPO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools